{"changeSha256":"0fbf982a043564635e4890b7e8714efa6ea45f8347e2ede6db3bd1d1d2814051","changedAt":"2026-07-27","changedFields":[{"after":"An amylin analogue candidate. This profile cites a ClinicalTrials.gov study record that was not yet recruiting.","before":"An amylin analogue candidate represented in ClinicalTrials.gov.","field":"Profile summary"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/petrelintide/versions/2/","version":2},"id":"profile:petrelintide:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-updated","notice":"We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change.","peptideSlugs":["petrelintide"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/petrelintide/versions/1/","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"ctg-nct07589686-v3","name":"ClinicalTrials.gov","sourceClass":"A","title":"Petrelintide With Enicepatide in Adults With Obesity or Overweight · record history version 3 · last update posted 2026-07-07","url":"https://clinicaltrials.gov/study/NCT07589686?a=3&tab=history","verifiedAt":"2026-07-22"}],"subject":{"slug":"petrelintide","type":"profile"}}